Preview

Current Pediatrics

Advanced search

EFFICACY OF THE IMMUNOSUPPRESSIVE THERAPY AGAINST THE NEPHROTIC SYNDROME AMONG CHILDREN

Abstract

The researchers evaluated the efficacy of different immunosuppressive medications in case of steroid dependent and steroid resistant variants of the nephrtic syndrome among children: traditional alkylating agents (cyclophosphamide, chlorbutin), cyclosporine and mycophenolate mofetil. Cyclosporine proved to be most efficient in treatment against steroid dependent nephritic syndrome, as the researchers were more often able to cancel the steroids, while the recurrence of the nephritic syndrome developed less often. In the event of the steroid resistant nephritic syndrome, the full/partial remission was achieved among more than 80% patients also treated by cyclosporine. In case of the proliferating forms of the steroid resistant nephritic syndrome, the positive outcome was achieved among all the children under observation, if mycophenolate mofetil and steroids were further applied. Therapy by the conventional alkylating agents (cyclophosphamide, chlorbutin) proved to be less efficient both for the relief from the steroid dependence and persistent remission of the steroid resistant nephritic syndrome.
Key words: nephritic syndrome, immunosuppressive therapy, alkylating agents, cyclosporine, mycophenolate mofetil, children.

About the Authors

A.G. Timofeeva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation




T.V. Sergeeva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


T.V. Margieva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


T.S. Voznesenskaya
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation



O.V. Komarova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


A.N. Tsygin
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


References

1. Clark A.G., Barratt T.M. Steroid Responsive Nephrotic Syndrome. In: Pediatric Nephrology. Ed. Barratt T.M., Avner E.D., Harmon W.E. 1999. P. 731–747.

2. International Study of Kidney Disease in Children. Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J. Pediatr. 1982; 101: 514–518.

3. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J. Pediatr. 1981; 98: 561–564.

4. Barratt T.M., Soothill J.F. Controlled trial of cyclophosphamide in steroid sensitive relapsing nephrotic syndrome of childhood. Lancet. 1970; 2: 479–482.

5. International Study of Kidney Disease in Children. Prospective controlled trial of cyclophosphamide in children with nephrotic syndrome. Lancet. 1974; 2: 423–427.

6. Barratt TM, Bercowsky A., Osofsky S.G. et al. Cyclophosphamide treatment in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet. 1975; 1: 55–58.

7. Garin E.H., Pryor N.D., Fennell R.S. et al. Pattern of response to prednisone in idiopathic minimal lesion nephrothic syndrome as a criterion selecting patients for cyclophosphamide therapy. J. Pediatr. 1978; 92: 304-308.

8. Geary D.F., Farine M., Thorner P. et al. Response to cyclophosphamide in steroid resistant focal segmental glomerulosclerosis. A reappraisal. Clin. Nephrol. 1984; 22: 109–113.

9. Niaudet P., Habib R. Cyclosporine in the treatment of idiopathic nephrosis. J. Am Soc. Nephrol. 1994; 5: 1049–1051.

10. Gellermann J., Querfeld U. Frequently relapsing nephrotic syndrome:treatment with mycophenolate mofetil. Pediatr. Nephrol. 2004; 19: 101–104.

11. Сергеева Т.В. Влияние комплексной терапии на течение и исход хронического гломерулонефрита у детей. Автореф. …дис. докт. наук. М. 1988. 46 с.

12. Moudgil A., Bagga A., Jordan S.C. Mycophenolate mofetil therapy infrequently relapsing steroid-dependent and steroid-resistant nephritic syndrome of childhood: current status and future directions. Pediatr. Nephrol. 2005; 20: 1376–1381.

13. Hsu A.C., Folami A.O., Bain J. et al. Gonadal functions in males treated with cyclophosphamide for nephrotic syndrome. Fertil. Steril. 1979; 31: 173–177.

14. Trompeter R.S., Evans P.R., Barratt T.M. Gonadal function in boys with steroid responsive nephrotic syndrome treated with cyclophosphamide for short periods. Lancet. 1981; 1: 1177–1179.

15. Buchanan J.D., Fairley K.F., Barris J.U. Return of spermatogenesis after stopping cyclophosphamide therapy. Lancet. 1975; 156–157.

16. Muller W., Brandis M. Acute leukemia after cytotoxic treatment for non malignant disease in childhood. Eur. J. Pediatr. 1981; 136: 105–108.

17. Niaudet P. Steroid-Resistant Idiopathic Nephrotic Syndrome. In: Barratt T.M, Avner E.D, Harmon W.E. Pediatric Nephrology. 1999. P.749–763


Review

For citations:


Timofeeva A., Sergeeva T., Margieva T., Voznesenskaya T., Komarova O., Tsygin A. EFFICACY OF THE IMMUNOSUPPRESSIVE THERAPY AGAINST THE NEPHROTIC SYNDROME AMONG CHILDREN. Current Pediatrics. 2007;6(5):113-116.

Views: 790


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)